According to reports from the Associated Press and others, some time late last Thursday the US Food & Drug Administration (FDA) appears to have approved the use of the FoundationOne CDx genetic/genomic test for patients with “advanced or widely spread cancers.” A media release from Foundation Medicine is also available on line. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: CDx, FoundationOne, genetics, genomics, test | 6 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 